Novel Concepts to Treat Myocardial Infarction Beyond Coronary Revascularisation

作为心脏病专家，我们在重新打开导致心脏病发作的阻塞动脉方面做得更好/更快。然而，随着这种重新开放，炎症血细胞在先前缺氧的心肌中流动并攻击它，矛盾的是造成进一步的损伤和心力衰竭。我们现在的目标是开发新颖的、高度创新的生物技术和基于纳米粒子的药物，使小血管保持畅通，防止炎症反应的形成，最终挽救心脏组织和生命。

As heart specialists we got better/faster in reopening blocked arteries that cause heart attacks. However, with this reopening, inflammatory blood cells flow in previously oxygen-deprived heart muscle and attack it and paradoxically cause further damage and heart failure. We now aim to develop novel, highly innovative biotechnological and nanoparticle-based drugs that keep the small vessels open and prevent the build-up of an inflammatory reaction, ultimately rescuing heart tissue and lives.